Due to its α2 receptor antagonism it is capable of enhancing therapeutic effects of antipsychotics, possibly by enhancing dopamine neurotransmission in the prefrontal cortex of the brain, a brain area thought to be involved in the pathogenesis of schizophrenia.

Mice treated with idazoxan, which blocks the α2A receptor which regulates norepinephrine, behaved similarly to control animals despite still having amyloid-beta plaques in the brain, as a proof-of-concept experiment that dramatically reduced Alzheimer's pathology and symptoms in two mouse models, potentially offering an immediate treatment for this devastating disease.

[5] Note that the literature method claims that the old original patented procedure gives a different reaction product formed through a rearrangement.

Pinner reaction with alcoholic hydrogen chloride leads to the iminoether,[11] (4).

Treatment with ethylenediamine [107-15-3] (5) gives the imidazoline ring affording Idazoxin (6).